Babesia in florida how travel and transfusion facilitate infection
Download
1 / 37

NYC Wedding Chapel Merchandise Recommendation - PowerPoint PPT Presentation


  • 279 Views
  • Uploaded on

Babesia in Florida: How Travel and Transfusion Facilitate Infection. Amber Barnes, MPH FL-EIS Fellow, Epidemiology Duval County Health Department. Presentation Objectives. To provide an overview of the current epizootiology of Babesia Describe routes of Babesia transmission

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'NYC Wedding Chapel Merchandise Recommendation' - mike_john


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Babesia in florida how travel and transfusion facilitate infection l.jpg

Babesia in Florida: How Travel and Transfusion Facilitate Infection

Amber Barnes, MPH

FL-EIS Fellow, Epidemiology

Duval County Health Department


Presentation objectives l.jpg
Presentation Objectives Infection

  • To provide an overview of the current epizootiology of Babesia

  • Describe routes of Babesia transmission

  • Describe the potential impact of Babesia on Floridians


Background of babesiosis l.jpg
Background of Babesiosis Infection

  • Zoonotic infection of a protozoan parasite “Babesia”

    • causes “Babesiosis”

  • Transmitted through:

    • Ixodesscapularisdeer ticks

    • transfusion of infected blood products

    • and congenitally

  • Parasites invade the erythrocytes, or red blood cells

    • causes asymptomatic, acute, andchronicinfections


Epidemiology of babesia l.jpg
Epidemiology of Babesia Infection

  • There are over 100 known species of Babesia1

  • The species known to parasitize in humans include:2

  • B. microti is the most common species to cause infection in humans in America

  • B. divergens is the most common species infecting humans in Europe

  • - B. microti - B. duncani

  • - B. microti-like - B. duncani-like

  • B. divergens - B. ovis-like

  • B. divergens-like - B. bovis

  • - B. canis


Transmission l.jpg
Transmission Infection

  • Ixodes scapularis- black-legged deer tick

    • Larval stage= feeds on white-footed mouse

    • Nymphal stage= feeds on humans and white-tailed deer

DIME

From http://fubyss.ento.vt.edu/vagm/enemies.html

From http://www.ent.iastate.edu/imagegal/ticks/iscap/


Transmission6 l.jpg
Transmission Infection

B. microti transmission

Life Cycle of I. scapularis tick

RESEVOIR:

White footed mouse and other rodents

VECTOR/ PRIMARY HOST:

Black-legged deer tick

SECONDARY HOST:

mammals, i.e. humans

Courtesy of D.W. Miller within Vannier, et al. Infectious Disease Clinics of N. America 22 (2008) 469–488.


Life cycle of babesia l.jpg
Life Cycle of Babesia Infection

Some Babesia species are transmitted at every stage of the tick’s life

Reprinted with gracious permission from K.-P Hunfeld et al. International Journal for Parasitology 38 (2008) 1219-1237as modified from Mehlhorn and Piekarski, 2002.


Transmission8 l.jpg
Transmission Infection

  • Additional transmission routes:

    • congenital/perinatal infection to baby

    • transfusion of blood from an infected donor

      • donor may be asymptomatic

      • currently no testing for Babesia in donated blood products or screening of blood product donors

      • parasite can survive for 35 days in refrigerated blood bank conditions3

      • patients receiving blood are immunocompromised or immunosuppressed


Infection l.jpg
Infection Infection

  • Asymptomatic infection

    • majority of cases are unaware of infection

    • parasitemia levels may be too low for detection

  • Chronic infection

    • can be infected for months, even years4

    • infected blood donors can transmit disease unknowingly

    • infected mothers have infected unborn babies and newborns

  • Acute infection

    • can cause severe illness and death

    • primarily affects immunocompromised/suppressed

      • especially asplenic and/or elderly patients5


Clinical symptoms l.jpg
Clinical Symptoms Infection

  • “Malaria-like” infection6

  • Common symptoms:

  • Additional symptoms may include:

  • Fever Fatigue

  • Chills Hemolytic anemia

  • Myalgia Jaundice secondary to anemia

  • HeadacheVomiting

  • Anorexia Thrombocytopenia

  • Nausea Normal or low WBC count


Infection11 l.jpg
Infection Infection

  • Most untreated infections will resolve but can take weeks to several months

  • Incubation Period of Babesiosis:

    • ranges from 1 week to several months

      • generally shorter for tick-borne transmission

      • can be longer for transfusion transmission

  • Period of Communicability:

    • very rare person-to-person transmission:

      • congenital/perinatal

      • transfusions of infected blood


Diagnosing babesiosis l.jpg
Diagnosing Babesiosis Infection

**CURRENTLY NOT REPORTABLE IN FLORIDA**

  • Can be difficult to diagnose

  • Things to remember…

    • Babesia is not endemic to our area

      • may not be considered in the differential diagnosis

    • Babesia is often discovered by our state labs testing blood for malaria

    • different Babesia species show up through different diagnostic methods


Diagnosing babesia l.jpg

tetrad Infection

Diagnosing Babesia

  • Diagnosed through the identification of the intraerythrocitic parasites on Giemsa- or Wright-stained thick or thin blood smears7

    • can be very difficult to distinguish from Plasmodium falciparum

    • look for the disease-specific

      “Maltese cross”

      • only visible during

        Merozoite stage


Diagnosing babesia14 l.jpg
Diagnosing Babesia Infection

  • Once identified, more serologic and molecular testing is performed by:

    • a reference laboratory

      • confirms diagnosis

    • CDC’s parasitology lab

      • confirm diagnosis

      • and/or determine species

    • animal innoculation

      • can take up to two weeks for results8


Guess that parasite l.jpg
Guess That Parasite! Infection

B. microti

B. microti

B. divergens

B. divergens

B. venatorum

B. venatorum

B. venatorum

P. vivax

P. falciparum

Images courtesy of the Liverpool School of Tropical Medicine and arrow sources from Häselbarth et al 2007 and Hildebrandt et al 2008.


Treatment l.jpg
Treatment Infection

  • Asymptomatic infection is rarely treated

  • General recommended treatment for immunocompetent individuals includes:

    • Clindamycin

      + PLUS

    • Quinine or Quinidine

    • 7 to 10 day treatment

    • can result in side effects that merit use of alternative drugs


Treatment17 l.jpg
Treatment Infection

  • Recommended treatment for individuals immunocompromised or those with very high parasitemia levels includes:

    • Azithromycin

      + PLUS

    • Atovaquone

    • 7 to 10 day treatment

    • some research indicates new resistance9

  • In rare instances of severe infection, exchange transfusions are given10


Wisconsin case definition example l.jpg
Wisconsin Case Definition Example Infection

  • Confirmed Babesiosis:

  • A clinically compatible illness that is laboratory confirmed. OR

  • A patient who is lab-confirmed or who would meet the serology criteria of a probable case, regardless of symptomatology, who is epidemiologically linked to a confirmed case acquired via transfusion


Wisconsin case definition example19 l.jpg
Wisconsin Case Definition Example Infection

  • Probable Babesiosis:

  • A clinically compatible illness with demonstration of a Babesia-specific antibody titer of at least 1:256 with an indirect fluorescent antibody (IFA) test for total Ig or IgG. The titer should be at least 1:1024 for infection with WA1-type parasites.

    • Comments:Confirmation of the diagnosis of babesiosis by a reference laboratory is strongly encouraged. The validity of the diagnosis of babesiosis is highly dependent on the laboratory that does the testing. For example, differentiation between malaria and Babesia parasites on peripheral blood smears can be very difficult.

      From http://hanplus.wisc.edu/epinet/reports/CDES101_babesia.pdf


Cases examples l.jpg
Cases Examples Infection

  • Case #1: Wedding-acquired Babesiosis in NY

    • 73 y/o female

    • Arrived at ED after passing out in her doctor’s waiting room

      • Had fever at night for last two weeks and anemia

    • Exposure risk:

      • Previous month she had traveled to Connecticut for an outdoor wedding

      • No memory of a tick bite

      • RBC transfusion at hospital

    • Peripheral smear showed parasites

      • Considered malaria at first

      • B. microti was confirmed instead

    • Treated successfully with a 14 day course of Atovaquone and Azithromycin11


Cases examples21 l.jpg
Cases Examples Infection

  • Case #2: Probable congenital in NJ

    • 26 day old infant

    • Transferred to hospital for evaluation

      • Complaints of fever, hyperbilirubinemia, not feeding well, irritable, and gagging

      • Mother, a migrant crop worker, noticed the infant had yellow eyes

    • Exposure risks:

      • No travel by mom or baby

      • No tick exposure to child

      • Mother had been bitten by two ticks while 8 months pregnant

      • RBC transfusion at hospital

    • Peripheral blood smear discovered B. microti

    • Treated successfully with Atovaquone and Azithromycin12


Florida cases l.jpg
Florida Cases Infection

  • Case #3: Probable transfusion transmitted

    • 74 y/o male

    • Arrived at ED on 4/11/2009

      • Complaints of anemia and syncope

      • Patient had a recent aneurysm repair

    • Parasites present on peripheral smear

      • malaria test was conducted on 4/12/2009

    • Results were positive for Babesia, negative Malaria

      • B. microti IgM level was <1:10 with the range being Neg: <1:10

      • B. microti IgG level was Neg. >1:320 with the range being Neg: <1:10

        • Negative IgM and positive IgG serology may indicate a pervious or current babesiosis infection


Florida cases23 l.jpg
Florida Cases Infection

  • Case #3 Cont.: Probable transfusion

    • DSI Laboratory reviewed the specimen and confirmed it was Babesia

    • Exposure risks:

      • No memory of tick bite

      • No travel outside of the U.S. in >50 years

      • Transfusion history in past year

    • Reported internally with the blood bank in April and to the FDOH in September


Florida cases24 l.jpg
Florida Cases Infection

  • Case #3 Cont.: Probable transfusion

  • Total of 27 different donors were used for patient

    • 17 donors subsequently tested negative

    • 10 were lost to follow up


Florida cases25 l.jpg
Florida Cases Infection

  • Case #4: Travel and transfusion exposures

    • 60 y/o male

    • Arrived at ED on 8/28/09

      • Complaints of dizziness, intermittent fevers, fatigue, and several falls

      • Once admitted, patient had severe anemia, thrombocytopenia, leukopenia and severe abdominal pain

      • CT scan found patient had a lacerated spleen

    • Patient underwent a splenectomy and transfusion

      • 6 units of RBCs and 2 units of platelets administered 8/28/09 through 9/5/09


Florida cases26 l.jpg
Florida Cases Infection

  • Case #4 Cont.: Travel/transfusion exposures

    • Patient developed a post-op fever

      • Blood smears interpreted as possible malaria

      • State lab looked at smears at suspected babesiosis

      • Specimens forwarded to CDC’s Parasitology Lab

        • Confirmed B. microti diagnosis

    • Exposure risks:

      • Travel to Massachusetts for 5 weeks with a return date of 8/1/09

      • No known tick bites

      • No confirmed previous Babesia infection

      • Transfusion history in past year

        • Blood bank attempted to inform donors of potential infection

    • Patient treated with Azithromycin and Atovaquone


Florida cases27 l.jpg
Florida Cases Infection

  • Case #5: Confirmed transfusion exposure

    • 84 y/o male

    • Admitted to hospital in February, 2008 with a GI bleed

      • Given RBC and plasma transfusions due to surgical repair

    • Patient returned to hospital 3/18/08

      • Complained of fever, chills, diarrhea, sweats, back pain, and anorexia

    • Peripheral blood smear at hospital was suspect for malaria

    • State lab confirmed sample was negative for malaria but positive for B. microti

    • Patient treated successfully and recovered


Florida cases28 l.jpg
Florida Cases Infection

  • Case #5 Cont.: Confirmed transfusion exp.

    • Blood banks did a trace back to find infected donor

      • 3 units of blood and 2 units of plasma given 2/8 and 2/11

      • 3 separate RBC donors

        • 2 Florida residents

        • 1 vacationing Wisconsin resident

    • FDOH developed questionnaire based on Babesia forms from endemic states for blood bank to use

    • Found Wisconsin donor to be infected

      • Donor was asymptomatic

      • Owned a cabin in the woods of an endemic state

      • Donated here and in home state of Wisconsin

      • Wisconsin blood banks had to be notified of donor’s status

      • Upon diagnosis, donor was reported in Wisconsin state data


Expanding babesia range l.jpg
Expanding Babesia Range Infection

  • Residential development in tick-prone wooded areas

  • More interaction with a growing population of deer11

  • B. microti is already endemic and reportable in:

    • Northeastern United States

      • Connecticut

      • Massachusetts

      • New Jersey

      • New York

      • Rhode Island

    • Upper Midwestern United States

      • Wisconsin

      • Minnesota

  • Prior travel history to these areas may indicate potential exposures in cases


Expanding babesia range30 l.jpg
Expanding Babesia Range Infection

  • Prior to 2001, most NY cases were residents of Long Island or those with travel to endemic areas

  • In 2001, there were 5 confirmed locally-acquired cases in residents of the Lower Hudson Valley, north of the endemic area with no travel or recognized risk factors

  • NY Dept. of Health collected 1,139 I. scapularis ticks from 5 areas in the Lower Hudson Valley and found B. microti

  • Babesia is moving up the state13

Reprinted with from Kogut et al. Emerging Infectious Diseases 11, 3 (2005).


Expanding babesia range31 l.jpg
Expanding Babesia Range Infection

Table 1: Important Babesia spp. with zoonotic potential including recently recognized defined parasites

a Known to regularly parasitize humans; ?: unknown; (?): questionable.

b Unverified infections with B. canis and B. bovis have been reported (Gorenflot et al., 1998), though it is likely that B. bovis infections are in fact B. divergens.

Reprinted with gracious permission from K.-P Hunfeld et al. International Journal for Parasitology 38 (2008) 1219-1237.


Surveillance l.jpg
Surveillance Infection

  • The FDA, CDC, CSTE, and other public health organizations have recently determined transfusion-transmitted Babesia to be a major public health concern

  • Florida is currently discussing how best to investigate future Babesia cases, especially in regard to transfusion transmitted cases

  • A draft of a Standard Operating Procedure for Babesia case follow up in Florida residents will be completed in the coming months


Preventing tick borne infection l.jpg
Preventing Tick-borne Infection Infection

  • Use protective measures when outdoors

    • avoid tick-prone areas May through October

    • choose light colored clothing

    • wear long sleeves and pants

      • tuck pants into boots

    • use tick and insect repellents that contain DEET

    • inspect yourself for ticks

      • if you find one, remove it with clean tweezers by gently pulling it straight away from the body, not twisting, and wash the area immediately14

    • provide your pets monthly tick prevention medications


Slide34 l.jpg

Questions? Infection

Courtesy of http://giveavoice.files.wordpress.com/2009/06/questions.jpg


References for slide material l.jpg
References for Slide Material Infection

1Gray, J.S., Weiss, L.M. 2008. Babesia microti. In: Khan, N. (Ed.), Emerging Protozoan Pathogens. Taylor and Francis, Abingdon, UK, pp. 303-349.

2Hunfeld, K.-P. et al., 2008. Babesiosis: Recent Insights into an Ancient Disease. International Journal for Parasitology, 38, 1219-1237.

3Emerging Health Threats Forum. (2009). Babesiosis: call for better blood screening. Retrieved on March 23rd, 2010 from http://www.eht-forum.org/news.html?targetPage=news/fulltext/news091023073616.html&from=search.

4Dobroszycki, J. et al., 1999. A Cluster of Transfusion-Associated Babesiosis Cases Traced to a Single Asymptomatic Donor. JAMA, 281(10), 927-930.

5Heymann, D.L. 2008. Babesiosis. In. Heymann, D.L. (Ed.), Control of Communicable Diseases Manual. American Public Health Association, Washington, D.C., USA, p.p.69-72.

6Weld, E.D., Eimer, K.M., Saharia, K., Orenstein, A., & Hess, J.R. 2010. The expanding range and severity of babesiosis. Transfusion 50, 290-291.

7Pickering, L.K. 2009. Babesiosis. In. Pickering, L.K., Baker, C.J., Kimberlin, D.W., Long, S.S., (Eds). Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. American Academy of Pediatrics, Elk Grove, IL, USA. p.p. 226-227.

8Asad, S., Sweeney, J., & Mermel, L.A., 2009. Transfusion-transmitted babesiosis in Rhode Island. Transfusion, 49(12), 2564-2573.

9Wormser, G.P., et al. 2010. Emergence of Resistance to Azithromycin-Atovaquone in Immunocompromised Patients with Babesia microti Infection. Clinical Infectious Diseases 50, 381-386.

10Leiby, D.A. 2006. Babesiosis and blood transfusion: flying under the radar. Vox Sanguinis 90, 157-165.

11Rawling, R.A., et al. 2009. A Case of Wedding-Acquired Babesiosis. Clinical Microbiology Newsletter 31(15), 116-118.

12Sethi, S. et al., 2009. Probable Congenital Babesiosis in Infant, New Jersey, USA. Emerging Infectious Diseases, 15(5)

13Kogut, S.J. et al., 2005. Babesiamicroti, Upstate New York. Emerging Infectious Diseases, 11(3).

14American Lyme Disease Foundation, Inc. (2010). Lyme Disease, How to Remove a Tick. Retrieved March 23rd, 2010 from http://www.aldf.com/lyme.shtml#removal.


References for graphics and table l.jpg
References for Graphics and Table Infection

  • http://fubyss.ento.vt.edu/vagm/enemies.html

  • http://www.ent.iastate.edu/imagegal/ticks/iscap/

  • D.W. Miller within Vannier, E. et al., 2008. Human Babesiosis. Infectious Disease Clinics of N. America 22, 469- 488.

  • K.-P Hunfeld et al., Babesiosis: Recent Insights into an Ancient Disease. International Journal for Parasitology, 38, as modified from Mehlhorn, H. & Piekarski, G., 2002. Grundriß der Parasitenkunde, 6th revised edition. Spektrum Akademischer Verlag GmbH, Heidelberg, Berlin, Germany, pp. 38-39.

  • ASM http://www.MicrobeLibrary.org

  • Liverpool School of Tropical Medicine and arrow sources from Häselbarth, K. et al., 2007, First Case of human babesiosis in Germany- Clinical presentation and molecular characterization of the pathogen. International Journal of Medical Microbiology 297, 197-204 and Hildebrandt, A. et al., 2008, Human babesiosis in Germany: Just overlooked or truly new?. International Journal of Medical Microbiology 298, 336-346.

  • http://hanplus.wisc.edu/epinet/reports/CDES101_babesia.pdf

  • Kogut, S.J. et al., 2005. Babesiamicroti, Upstate New York. Emerging Infectious Diseases, 11(3).

  • http://giveavoice.files.wordpress.com/2009/06/questions.jpg


Contact information l.jpg
Contact Information Infection

Amber Barnes, MPH

EIS Fellow,

FL DOH

(904) 253-1864

[email protected]

Robyn Kay, MPH

Regional Epidemiologist,

FL DOH

(904) 791-1747

[email protected]

Danielle Stanek, DVM

Medical Epidemiologist,

FL DOH

(850) 294-1087

[email protected]

Beth Radke, MPH

Arbovirus Surveillance Coordinator,

FL DOH

(850) 245-4444 ext. 2437

[email protected]

Please visit the CDC’s website on Babesiosis at http://www.cdc.gov/babesiosis/ for more information.


ad